Our press pages provide up-to-date information on important developments at the High-Tech Gründerfonds and in the HTGF family. This also includes news from our portfolio companies.

We are convinced that a strong start-up ecosystem is important for Germany as a business centre. As Europe’s most active early-stage investor, with around 900 million euros under management, we are an important part of this ecosystem. We want to strengthen it, which also involves providing information about our work. We are the media’s go-to contact for all matters relating to start-ups, venture capital and, of course, our portfolio companies. Please get in touch with us.

22. October 2020

HTGF Investment NOVUM engineering

Innovation leader for large-scale battery storage monitoring NOVUM secures capital increase for product portfolio expansion Dr. Hettich Beteiligungen and High-Tech
21. October 2020

HTGF Exit Synoste Oy

Successful exit for High-Tech Gründerfonds and Evonik Venture Capital – Synoste Oy becomes part of Globus Medical Globus Medical, based
20. October 2020

HTGF Exit ChromoTek

Successful exit for High-Tech Gründerfonds and Bayern Kapital –Proteintech acquires ChromoTek Proteintech, which is based in Chicago, Illinois, USA, is HTGF Exit ChromoTek
20. October 2020

HTGF News Atriva Therapeutics

HTGF portfolio company: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment European Investment